Trial Details
COMPLETEDBasic Information
| Clinical ID | c1871 |
|---|---|
| Identifier | NCT05602116 |
| Trial Title | ASC - Autism Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Autism Spectrum Disorder; Gastrointestinal Dysfunction; Leaky Gut Syndrome; Mesenchymal Stromal Cells; Inflammatory Bowel Diseases |
| Interventions | DRUG: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®) |
Participant Information
| Sponsor | Cell2Cure ApS |
|---|---|
| City | Aalborg |
| Country/Region | Denmark |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-06-09 |
|---|---|
| Primary Completion Date | 2024-06-28 |
| Completion Date | 2024-09-20 |